Reduced incidence of infusion-related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication-Reference-Cited by-同舟云学术

Reduced incidence of infusion-related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication

Published:2010-04-01 Issue:7 Volume:116 Page:1827-1837
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Siena Salvatore,Glynne-Jones Robert,Adenis Antoine,Thaler Josef,Preusser Peter,Aguilar Enrique Aranda,Aapro Matti S.,Loos Anja H.,Esser Regina,Wilke Hansjochen

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24945/fullpdf

Reference33 articles.

1. Comparing antibody and small-molecule therapies for cancer;Imai;Nat Rev Cancer.,2006

2. Novel antibodies as anticancer agents;Zafir-Lavie;Oncogene.,2007

3. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management;Hewitt;Clin Colorectal Cancer.,2006

4. Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients;Navo;Gynecol Oncol.,2006

5. Novel formulations of taxanes: a review. Old wine in a new bottle?;Hennenfent;Ann Oncol.,2006

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?;BMC Cancer;2022-11-25

2. Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2);International Journal of Clinical Oncology;2022-08-24

3. How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?;Frontiers in Immunology;2021-11-01

4. Neurotoxicity of poly(propylene imine) glycodendrimers;Drug and Chemical Toxicology;2020-11-13

5. Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigation;Asia-Pacific Journal of Clinical Oncology;2020-09-24